Election Process

The NNECOS Board of Directors Election will be conducted via online voting, in advance of the annual meeting.  The election requires a minimum of 10 percent of the voting-eligible members to participate to be valid.

Online voting will be open from September 1-21, 2021. Active NNECOS members in good standing (Active Physician and Active Associate) are eligible to vote in the election, and will receive an email with the voting link at noon on Wednesday, September 1st. (Please check your spam/promotions folder if you do not see the email from noreply@electionrunner.com.).

Results will be announced in early October, with the term to begin on Saturday, October 30th.

Active Associate Member Candidates


 

Emma L. Dann, DNP, RN, OCN, NEA-BC

Vice President, Network and Clinical Services

Dana-Farber Cancer Institute

Brenda Farnham MBA, BSN, RN, OCN

Associate Vice President, Oncology Services

Northern Light Health, EMMC Cancer Care

Emma is a Vice President of Nursing at the Dana-Farber Cancer Institute (DFCI).  Emma is responsible for and supports the ongoing clinical operations of DFCI’s satellite locations and collaborative sites to ensure continued excellence and quality of care.  She is also the clinical leader for Occupational Health Services and helped to lead the pandemic response for the Institute, including COVID testing and vaccine administration.  She is also provides nursing leadership oversight for the Nursing Informatics and Cancer Care Equity programs at DFCI.  She develops, implements, monitors, and reports on network nursing, clinical, and quality & safety metrics. She is also responsible for ensuring that nursing and clinical practice and policies and procedures meet regulatory requirements.

Prior to joining Dana-Farber in 2015, Emma was previously at Maine Medical Center as the Director of Oncology Nursing Services and Amgen as an Oncology Clinical Specialist.

Emma has a Bachelors of Science Degree in Nursing from the University of New Hampshire, a Masters of Science in Nursing Administration from Northeastern University, and a Doctorate of Nursing Practice with a focus in Executive Leadership from Simmons College.

She is a member of the Oncology Nursing Society (ONS), American Organization of Nurse Executives (AONE), Organization of Nurse Leaders (ONL), Northern New England Clinical Oncology Society (NNECOS) and an active volunteer in her local and professional community.

Candidate Statement

I am honored to be nominated to serve on the Northern New England Clinical Oncology Society Board of Directors. I have been a member of NNECOS since the beginning of my career as an oncology nurse in Maine. I continued to be involved throughout my career as an oncology nurse working in the clinical setting (Maine Medical Center and DFCI) as well as at Amgen.  I have always valued the educational and networking opportunities that NNECOS has to offer.  I have also been a volunteer for the Nursing and Allied Health Professional Advisory Committee (NAHPAC) and assisted the committee in planning educational opportunities. I always look forward to attending the Annual and Spring Meetings to learn and interact with my colleagues.  I have presented at NNECOS meetings and the OCN Review Course.

My current role is at the Dana-Farber Cancer Institute as a Vice President of Nursing. I am responsible for and support the ongoing clinical operations of DFCI’s community network and collaborative sites in NH, MA, and ME to ensure continued excellence and quality of care. I also provide nursing leadership support to our Occupational Health Services, Nursing Informatics, and Cancer Care Equity programs.  I am uniquely positioned to connect the academic campus to the care in the community to assure patients can receive quality care closer to home. I believe my professional experience (past and present) position me well to serve on the NNECOS Board. I hope you will give me a chance to represent and support you!

Brenda Farnham has been a member of the NNECOS Board of Directors since 2016.

Brenda is the AVP and Nurse Manager for Oncology Services for NLH EMMC Cancer Care.  She earned her Bachelor’s Degree in Nursing and a Master’s Level Degree and in Business and Healthcare Management from Husson [College] University.  Brenda has 31 years of experience in Critical Care, Medical, Pediatric and Radiation Oncology. She is a Husson University Alumni Hall of Fame 2009 Inductee, 2018 RTLS Innovator Recipient, and 2020 NNECOS Distinguished Service Award recipient. She enjoys outdoor activities, bicycling, antiques and snow.

Active Physician Member Candidates

     

Steven Ades, MD

Medical Oncologist

The University of Vermont Medical Center


YongLi Ji, MD

Medical Oncologist

Center for Cancer Care at Exeter Hospital

Julian R. Sprague, MD

Hematologist

Associate Professor

UVM Medical Center

Dr. Ades is a medical oncologist at the University of Vermont Medical Center and an associate professor at the Larner College of Medicine at UVM in Burlington, VT.

Candidate Statement:

I am an academic medical oncologist at UVM and have been an active member of the NNECOS BOD since 2014. I served as president in 2015-16. I also serve as co-leader of the education committee, and a member of the grant and abstract review committees since I joined the BOD.

My focus in the last year has been to serve on the Governance Committee assisting our Executive Director in reshaping this Society to grow, be more inclusive and meet the changing landscaping of cancer care in the coming years.

Growing up, I witnessed sad stories within my own family, caused by chronic health problems. The experience, combined with my compassion, motivated me to help the sick.

I graduated college with a MD degree, and then came to the US for PhD training in Molecular Biology at Brandeis University. After finishing, I completed residency at St. Vincent Hospital in Worcester, MA and Hematology/Oncology fellowship at UVMMC in Burlington, VT.

In 2015, I joined the Massachusetts General Physicians Organization to practice at Exeter Hospital in Exeter, NH. I am one of the designated oncologists for breast and lung cancer. I am also recognized by colleagues to see patients with clotting disorders as I have learned alongside UVMMC's benign hematology team. I have been an active member of the Institutional Review Board at Exeter, and learned to provide and promote the practice of high quality care through teaming up with other colleagues and staff. I am one of the key members of breast cancer leadership team in Exeter Hospital. I advocate patient care by initiating supportive activities, such as introductory TaiChi group. I was interviewed by the local newspapers discussing multiple topics including obesity’s association with cancer risk, immunotherapy treating lung cancer, and male breast cancer awareness.

I joined NNECOS as a fellow in 2012. During my last year of fellowship, I was a fellow liaison participating NNECOS’s board meeting. I have presented my research as posters and podium presentation. I was awarded a NNECOS research grant under the mentorship of Dr. Marie Wood. Since then, I have actively participated NNECO's meetings and activities. My goal is to bring NNECOS diversity, new blood and ideas; I am committed and looking forward to growing professionally with NNECOS.

I like a variety of physical activities and enjoy cooking. I am completing NH 4000 footers and truly appreciate nature's stunning spectacles. I started outdoor running during the COVID pandemic and finished my first marathon in Derry, NH this past spring.

I graduated from the University of Virginia School of Medicine in 2001. Subsequently, I performed my residency in internal medicine and fellowship in hematology/oncology at the University of Vermont Medical Center (UVMMC). I started as an attending in hematology at the UVMMC in 2007 and became Program Director of the hematology/oncology fellowship Program in 2010. Recently, I worked in conjunction with the planning committee of NNECOS to increase fellow and trainee participation in NNECOS and the NNECOS scientific meetings, which would continue to be part of my focus as a board member.  The covid pandemic has made us all rethink how we deliver education to our trainees, and I am excited by the prospect of working with the NNECOS board to find innovative ways to promote fellow, as well as other trainee research and education in hematology and oncology.

Over the past 5 years I have actively sought opportunities to do more for the Hematology/Oncology community. Beginning in 2016, I began serving on the American Society of Hematology Committee on Training (COT) and continue to be the liaison to the Committee on Quality from the COT. I have served in several different roles while on the COT. I was chair for two years of the Phys-Sci subcommittee which reviews proposals and awards research grants to aspiring hematologic researchers in medical school. I continue to serve on the subcommittee for developing a sickle cell educational experience for fellows, funded by ASH, to promote broader understanding of sickle cell disease, particularly for fellowships that have minimal exposure to these patients. Currently, I serve as chair of the Medical Education Subcommittee of the COT.

I hope that my experience as an educator, program director, and national committee member positions me to be a productive board member for NNECOS.

     

John P. Winters, III, MD

Hematology/Oncology

New England Cancer Specialists


Marie Wood, MD

Medical Oncologist

The University of Vermont Medical Center

 

Dr. Winters currently serves as president-elect for NNECOS and has served on the board of directors since 2017.  He received his medical degree from the University of Oklahoma-College of Medicine. He trained in internal medicine at the University of New Mexico and stayed an additional year as Chief Resident. He completed fellowship training at the University of Vermont where he and his wife fell in love with the people and landscapes of Northern New England.  

Having trained under Steve Grunberg and adhering to tradition at the University of Vermont, he was active in NNECOS throughout his fellowship. He presented new research at the annual meeting all three years of his training, including a podium presentation.  During his final year of fellowship, he served on the board as a fellow liaison.

Dr. Winters is a partner at New England Cancer Specialists with a practice focus in general hematology and melanoma.  He has remained active in NNECOS and served as an abstract/poster judge at the 2016 and 2017 annual meetings. In late 2017, he was elected to the NNECOS board of directors to fill a vacated seat.

Dr. Winters is board certified in internal medicine, hematology, and oncology with interests in benign hematology, malignant hematology, and melanoma. He is a member of the American Society of Hematology and American Society of Clinical Oncology. His interest in serving on the board of directors stems from his desire to actively pursue advocacy and joint interests for oncologists and cancer patients on a regional level.

Dr. Winters lives in Cape Elizabeth, ME with his wife and their 2 young children.  His outside interests include alpine and nordic skiing, snowshoeing, backpacking, running, cooking, and reading fiction. 

Dr. Marie E. Wood has been a member of the NNECOS Board of Directors since 2014, having served on the NNECOS Education Committee, Research Review Committee, Abstract Review Committee and as President of the Board for the past 2 years. Dr. Wood is a professor of medicine at the University of Vermont, Associate Director for Cancer Control and Public Health at the University of Vermont Cancer Center, Co-Chair for Prevention for the Alliance for Clinical Trials, Deputy Director of Cancer Control for the Alliance for Clinical Trials and the Editor in Chief of ASCO Digital Education.

Candidate Statement

I am an established and experienced clinician and researcher specializing in breast oncology and breast cancer prevention. I have a successful record of accomplishment as a PI, co-investigator, and collaborator in hereditary breast cancer and breast cancer prevention research, with current research efforts focused on breast cancer biomarkers and mammographic breast density (e.g., relation of density to breast cancer risk factors and other biomarkers; interventions and change in breast density).

I have held leadership roles in the cooperative groups (CALGB and ALLIANCE) since 2006, when I was appointed vice chair for the prevention subcommittee for CALGB. I continued that role through the merger of cooperative groups, serving as a vice chair for the Prevention Committee for ALLIANCE. In 2016, I was elected co-chair of Prevention and in 2017, I was appointed to the first NCI Prevention steering committee. During my tenure in leadership for both CALGB and ALLIANCE, there has been a progressive growth in prevention trials. I have been the national PI for 2 completed trials (statins/70806), one open (Alliance A211201/NCIC CTG MA.32D) and 1 in development (A211601 Evaluation of Mammographic Breast Density Effect of Aspirin: A Companion to Alliance A001502 A Randomized Phase III Double Blinded Placebo Controlled Trial of Aspirin as Adjuvant Therapy of Node Positive HER2 Negative Breast Cancer). I am Co-Director for Cancer Control and Public Health research at the University of Vermont Cancer Center. Over the course of my career, I have mentored over 30 students, residents, fellows and junior faculty, many of whom have gone on to successful academic careers.

I have also held leadership positions within ASCO and served on many committees including Publications, Prevention (Chairing the Genetics Sub Committee), Technology and Continuing Education (for which I am the current chair). Because of my experience in cancer prevention, clinical trials, my strong commitment training and mentoring of junior faculty and leadership within Alliance and ASCO, I am well positioned to continue to serve as a member of the NNECOS board. I have served as President of NNECOS for the past two years and feel that my experience and perspectives make me well suited to continue to serve on the Board of Directors.

 

Northern New England Clinical Oncology Society
P.O. Box 643
Sandown, NH 03873-0643
Telephone (603) 887-1948
info@nnecos.org

This website brought to you by:


Powered by Wild Apricot Membership Software